Asarina Pharma AB (OSTO:ASAP) Accounts Payable & Accrued Expense : kr0.63 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB Accounts Payable & Accrued Expense?

Asarina Pharma AB's quarterly accounts payable & accrued expense increased from Dec. 2022 (kr0.84 Mil) to Jun. 2023 (kr1.10 Mil) but then declined from Jun. 2023 (kr1.10 Mil) to Dec. 2023 (kr0.63 Mil).

Asarina Pharma AB's annual accounts payable & accrued expense declined from Dec. 2021 (kr2.47 Mil) to Dec. 2022 (kr0.84 Mil) and declined from Dec. 2022 (kr0.84 Mil) to Dec. 2023 (kr0.63 Mil).

Asarina Pharma AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Asarina Pharma AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Accounts Payable & Accrued Expense Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

16.61

11.31

2.47

0.84

0.63

Asarina Pharma AB Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial									2.47	1.00	0.84	1.10	0.63

Asarina Pharma AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Asarina Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB Headlines

No Headlines